Form 4: Phathom Pharmaceuticals CFO Molly Henderson Reports Stock Sale to Cover Tax Obligations

Molly Henderson, CFO and CBO of Phathom Pharmaceuticals, sold 1,291 shares of common stock on December 19, 2024, to cover tax withholding obligations related to the settlement of restricted stock units.

Summary

• On December 19, 2024, Molly Henderson, the CFO and CBO of Phathom Pharmaceuticals, sold 1,291 shares of the company's common stock.
• The sale was executed at a price of $8 per share.
• This transaction was reported on a Form 4 filing with the SEC.
• The purpose of the sale was to satisfy tax withholding obligations arising from the settlement of restricted stock units.
• Following the transaction, Henderson directly owns 98,156 shares of Phathom Pharmaceuticals common stock.
• Henderson also indirectly owns 1,911.27 shares of common stock through a 401(k).

Sentiment

Score: 5

Explanation: This is a neutral event. An executive sold shares to cover tax obligations, which is a normal financial activity.

Industry Context

Form 4 filings are a routine part of the regulatory landscape for publicly traded companies, providing transparency into the transactions of company insiders. This filing indicates that a high-ranking executive sold shares, which is a common occurrence for managing personal finances and covering tax obligations.

Stakeholder Impact

• The sale of shares by an executive could have a minor impact on shareholder sentiment, but is unlikely to be significant given the stated reason for the sale.

Key Dates